H-PDSLRDLSVF-OH

Ref. 3D-PP44572

Produktinformation

• Name: H-PDSLRDLSVF-OH
• Synonyme: NH2-Pro-Asp-Ser-Leu-Arg-Asp-Leu-Ser-Val-Phe-OH

Beschreibung

Peptide H-PDSLRDLSVF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-PDSLRDLSVF-OH include the following: Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigen ZA Lopez-Bujanda , MG Chaimowitz - , 2020 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/2162402X.2020.1809926 Coexpression of Flt3 ligand and GM-CSF genes modulates immune responses induced by HER2/neu DNA vaccine YT Yo, KF Hsu, GS Shieh, CW Lo , CC Chang - Cancer Gene , 2007 - nature.comhttps://www.nature.com/articles/7701081 Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8+ T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established Y Chen, Y Xie, T Chan, A Sami , S Ahmed , Q Liu - Cancer Gene , 2011 - nature.comhttps://www.nature.com/articles/cgt201118 HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination T Chan, A Sami , A El-Gayed, X Guo , J Xiang - Gene therapy, 2006 - nature.comhttps://www.nature.com/articles/3302797 Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and S Sas, T Chan, A Sami , A El-Gayed, J Xiang - Cancer Gene Therapy, 2008 - nature.comhttps://www.nature.com/articles/cgt200818 OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigen S Murata, BH Ladle, PS Kim , ER Lutz - The Journal of , 2006 - journals.aai.orghttps://journals.aai.org/jimmunol/article/176/2/974/73631 Chronic immune therapy induces a progressive increase in intratumoral T suppressor activity and a concurrent loss of tumor-specific CD8+ T effectors in her-2/neu RE Nair, MO Kilinc, SA Jones - The Journal of , 2006 - journals.aai.orghttps://journals.aai.org/jimmunol/article/176/12/7325/7501 Vaccination Strategy Determines the Emergence and Dominance of CD8+ T-Cell Epitopes in a FVB/N Rat HER-2/neu Mouse Model of Breast Cancer R Singh, Y Paterson - Cancer research, 2006 - AACRhttps://aacrjournals.org/cancerres/article-abstract/66/15/7748/525995 In the FVB/N HER-2/neu transgenic mouse both peripheral and central tolerance limit the immune response targeting HER-2/neu induced by Listeria monocytogenes R Singh, Y Paterson - Cancer Immunology, Immunotherapy, 2007 - Springerhttps://link.springer.com/article/10.1007/s00262-006-0237-4 Fusion to Listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse R Singh, ME Dominiecki, EM Jaffee - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/175/6/3663/73302 Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein P Cheng , CA Corzo, N Luetteke, B Yu - The Journal of , 2008 - rupress.orghttps://rupress.org/jem/article-abstract/205/10/2235/47046 In vivo antitumor function of tumor antigen-specific CTLs generated in the presence of OX40 co-stimulation in vitro N Pham Minh, S Murata, N Kitamura - Journal of Cancer, 2018 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.31244 Booster immunizations with DNA plasmids encoding HER-2/neu prevent spontaneous mammary cancer in HER-2/neu transgenic mice over life span M Provinciali , A Barucca, F Orlando , E Pierpaoli - Scientific reports, 2017 - nature.comhttps://www.nature.com/articles/s41598-017-03286-8 In vivo electroporation restores the low effectiveness of DNA vaccination against HER-2/neu in aging M Provinciali , A Barucca, E Pierpaoli, F Orlando - Cancer Immunology , 2012 - Springerhttps://link.springer.com/article/10.1007/s00262-011-1107-2 Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 L Wang, Y Xie, KA Ahmed , S Ahmed, A Sami - Breast cancer research , 2013 - Springerhttps://link.springer.com/article/10.1007/s10549-013-2626-7 Strategy for Identifying Dendritic Cell-Processed CD4+ T Cell Epitopes from the HIV Gag p24 Protein L Bozzacco, H Yu, J Dengjel , C Trumpfheller - PloS one, 2012 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0041897 Strategy for Identifying Dendritic Cell-Processed CD4+ T Cell Epitopes from the L Bozzacco, H Yu, J Dengjel , C Trumpfheller - 2012 - academia.eduhttps://www.academia.edu/download/88232109/7daa33128524a46b1c98748cf0f66ce9dab5.pdf A STING agonist given with OX40 receptor and PD-L1 modulators primes immunity and reduces tumor growth in tolerized mice JB Foote, M Kok, JM Leatherman , TD Armstrong - Cancer immunology , 2017 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/5/6/468/468831 Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer GH Nam , EJ Lee , YK Kim, Y Hong , Y Choi - Nature , 2018 - nature.comhttps://www.nature.com/articles/s41467-018-04607-9 Co-expression of Flt-3 ligand gene ablates tumor immunity elicited by HER-2/neu DNA vaccine in transgenic mice FM Venanzi, A Barucca, K Havas, M Capitani - Vaccine, 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X10003464 Dissecting the Mechanisms of T Cell Tolerance for More Effective Breast Cancer Vaccine Development PRINCIPAL INVESTIGATOR: Brian H. Ladle EM Jaffee - 2003 - apps.dtic.milhttps://apps.dtic.mil/sti/pdfs/ADA420387.pdf CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer E Righi, S Kashiwagi , J Yuan, M Santosuosso - Cancer research, 2011 - AACRhttps://aacrjournals.org/cancerres/article-abstract/71/16/5522/567664 tumor immune responses and delay of tumor development in human epidermal growth factor receptor 2 mice immunized with an immunostimulatory peptide in poly (D DF Campbell, R Saenz, IS Bharati, D Seible - Breast cancer , 2015 - Springerhttps://link.springer.com/article/10.1186/s13058-015-0552-9 Dissecting the Mechanism of T Cell Tolerance for More Effective Breast Cancer Vaccine Development BH Ladle, EM Jaffee - 2003 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA435335 S REPORT DOCUMENTATION PAGE OMB No. 074-0188 BH Ladle, EM Jaffee - 2004 - apps.dtic.milhttps://apps.dtic.mil/sti/pdfs/ADA435335.pdf Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor A Wallecha, R Singh, I Malinina - Journal of immunotherapy, 2013 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2013/11000/Listeria_monocytogenes__Lm__LLO_Immunotherapies.3.aspx

• Marke: Biosynth